Summary
Fourty-three of 61 patients suffering from low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification were subjected to an intermittent combination chemotherapy, with chlorambucil and prednisone. In 12 of 35 evaluable patients a complete remission, in 14 of 35 a partial remission could be achieved The mean remission time of patients with a complete remission exceeds 16 months, that of patients with a partial remission amounts to more than 8 months. In 9 of 35 cases a remission could not be achieved. As 10 of the 12 patients in whom a complete remission could be obtained are alive, the median survival time in cases of complete remission cannot yet be determined. The hematological toxicity was very low, nausea and lack of appetite were observed in 9 of 35 patients. Three of 35 treated and evaluable patients died, viz., 1 patient with a centroblastic-centrocytic, lymphoma and 1 patient with a chronic lymphocytic leukemia died from the sequelae of progression during the chemotherapy, of second choice according to the COP regimen. The third patient with a centroblastic-centrocytic lymphoma died from the sequelae of an intrahepatic cholestatic icterus, also during the chemotherapy, of second choice according to the COP regimen. In the lastmentioned case, autopsy also confirmed, a continuous complete remission of the centroblastic-centrocytic lymphoma.
Similar content being viewed by others
References
Bagley, C., De Vita, V. T., Berard, C. W., Canellos, G. P.: intensive cyclical combination chemotherapy, with cyclophosphamide, vincristine and prednisone. Ann. int. Med. 76, 227 (1972)
Bonadonna, G., Lattuada, A., Banfi, A.: Recent trends in the treatment of non-Hodgkin's lymphomas. Europ. J. Cancer 12, 661 (1976)
Brittinger, G., Bartels, H., Bremer, K., Dühmke, E., Gunzer, U., König, E. Stein, H. (Kieler Lymphomgruppe): Klinik der malignen Non-Hodgkin-Lymphome entsprechend der Kiel-Klassifikation: Centrocytisches Lymphom, centroblastisch-centrocytisches Lymphom, lymphoblastisches Lymphom, immunoblastisches Lymphom. In: Maligne Lymphome und monoklonale Gammopathien Löffler H. (ed.), Hämatologie und Bluttransfusion. Vol. 18, p. 211. München J. F. Lehmann 1976
Gérard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A.G., van Unnik, J. A. M.: Classification of non-Hodgkin's lymphomas. Lancet II, 406 (1974)
Han, T., Ezdinli, E. Z., Shimaoka, K., Desai, D. V.: Chlorambucil vs. combined chlorambucil-corticosteroid therapy in chronic lymphocytic leukemia. Cancer 31, 502 (1973)
Hoogstraten, B., Owens, A. H., Lenhard, R. E., Glidewell, O. J., Leone, L. A., Olson, K. B., Harley, J. B., Townsend, S. R., Miller, S. P., Spurr, C. L.: Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma. Blood 33, 370 (1969)
Jones, S. E., Fuks, Z., Bull, M., Kadin, M. E., Dorfman, R. F., Kaplan, H. S., Rosenberg, S. A., Kim, H.: Non-Hodgkin's lymphomas, IV. Clinicopathologic correlation in 405 cases. Cancer 31, 806 (1973)
Kennedy, B. J., Hill, J., Bloomfield, C., Kiang, D., Fortuny, I., Teologides, A.: Combination (COP) versus successive single agent chemotherapy (C-O-P) in lymphocytic lymphoma. Proc. Amer. Ass. Cancer Res. 16, 142 (1975)
Knospe, W. H., Loeb, V., Jr., Huguley C. M., Jr.: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33, 555 (1974)
Luce, J. K., Gamble, J. F., Wilson, H. E., Monto, R. W., Isaacs, B. L., Palmer, R. L., Coltman, C. A., Hewlett, J. S., Gehan, E. A., Frei III, E.: Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphoma. Cancer (Philad.) 28, 306 (1971)
Rappaport, H.: Tumors of the hematopoietic system. In: Atlas of Tumor Pathology Sect. Ill, Fasc. 8, Armed Forces Institute of Pathology. Washington, D.C. (1966)
Rosenberg, S. A., Kaplan, H. S.: Clinical trials in the non-Hodgkin's lymphomata at Stanford University. Experimental design and preliminary results. Br. J. Cancer (Suppl. II) 31, 456 (1975)
Schein, P. S., Chabner, B. A., Canellos, G. P., Young, R. C., Berard, C., De Vita, V. T.: Potential for prolonged disease free survival following combination chemotherapy, of non-Hodgkin's lymphoma. Blood 43, 181 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stolzenbach, G., Garbrecht, M. Intermittent combination chemotherapy with chlorambucil and prednisone of low-grade malignant non-Hodgkin's lymphomas according to the Kiel classification. J Cancer Res Clin Oncol 93, 189–194 (1979). https://doi.org/10.1007/BF00406577
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00406577